{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06298981",
            "orgStudyIdInfo": {
                "id": "2301"
            },
            "organization": {
                "fullName": "Nuralogix Corporation",
                "class": "INDUSTRY"
            },
            "briefTitle": "Pulse Rate and Breathing Rate Accuracy",
            "officialTitle": "Pulse Rate and Breathing Rate Accuracy Study - NuraLogix AMC-SDK",
            "therapeuticArea": [
                "Other"
            ],
            "study": "pulse-rate-and-breathing-rate-accuracy"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-03",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-02-12",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-06-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-06-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-03-01",
            "studyFirstSubmitQcDate": "2024-03-01",
            "studyFirstPostDateStruct": {
                "date": "2024-03-07",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-03-21",
            "lastUpdatePostDateStruct": {
                "date": "2024-03-22",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Nuralogix Corporation",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to conduct a Breathing Rate and Pulse Rate accuracy validation comparing the NuraLogix AMC-SDK to the Reference devices, an FDA cleared End Tidal Carbon Dioxide monitor (GE Datex-Ohmeda) and a standard ECG (GE Datex-Ohmeda) derived heart rate reference. This will be done by manually scoring the collected waveform for data analysis."
        },
        "conditionsModule": {
            "conditions": [
                "Pulse Rate and Breathing Rate"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "CROSS_SECTIONAL"
            },
            "enrollmentInfo": {
                "count": 60,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "interventions": [
                {
                    "type": "DEVICE",
                    "name": "noninvasive and investigational NuraLogix AMC-SDK",
                    "description": "The NuraLogix AMC-SDK is a noninvasive device that allows for real-time, remote measuring using facial recordings."
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Breathing rate accuracy validation",
                    "description": "The purpose of this study is to conduct a Breathing Rate accuracy validation comparing the NuraLogix AMC-SDK to the Reference, an FDA cleared End Tidal Carbon Dioxide monitor (GE Datex-Ohmeda) by manually scoring the collected waveform for data analysis",
                    "timeFrame": "1-2 hours"
                },
                {
                    "measure": "Pulse rate accuracy validation",
                    "description": "This study will also assess the pulse rate measurements of the NuraLogix AMC-SDK for comparison to a standard ECG (GE Datex-Ohmeda) derived heart rate reference.",
                    "timeFrame": "1-2 hours"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Pulse rate simulation",
                    "description": "To assess a broader pulse rate range by manipulating the speed of recorded videos.",
                    "timeFrame": "1-2 hours"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Participants must have the ability to understand and provide written informed consent or have legally authorized representative consent to participate\n* Participant must be 18 to 81 years of age (\u2265 18 age to \\< 82)\n* Participant must be willing and able to comply with study procedures and duration\n* Participants or legally authorized representative must be able to read or write in English\n\nExclusion Criteria:\n\n* Participants who refuse or are unable to provide to sign an informed written consent for study\n* Participants evaluated by the Investigator and Clinical Staff and found to be medically - unsuitable or have self-reported health conditions that are currently unstable as identified in the Health Assessment Form and Health Screening\n* Compromised circulation, injury, or physical malformation of fingers, toes, hands, ears or forehead/skull or other sensor Region of Interest (ROI) which would limit the ability to test ROI needed for the study. Tattoo in the optical path which would limit the ability to test ROI needed for the study. (Note: Certain malformations may still allow participants to participate if the condition is noted and would not affect the particular areas utilized.)\n* Participants with severe contact allergies to standard adhesives, latex or other materials found in pulse oximetry sensors, ECG electrodes, or other medical sensors (self- reported)\n* Other known health condition, should be considered upon disclosure in health assessment form",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "81 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "The study population will be comprised of diversity in race, age, gender, BMI, skin tone, and health conditions. The health conditions will constitute inclusion of healthy controls (to allow testing over the full range of breaths per minute) and disease comorbidities (to represent comorbidities such as COPD, CHF, Asthma, Diabetes, Hypertension, and Obesity). An attempt will be made to enroll a variety of skin tones.",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Roberto Liddi",
                    "role": "CONTACT",
                    "phone": "(647) 578-7925",
                    "email": "robertoliddi@nuralogix.ai"
                }
            ],
            "locations": [
                {
                    "facility": "Element Materials Technology",
                    "status": "RECRUITING",
                    "city": "Louisville",
                    "state": "Colorado",
                    "zip": "80027",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Monica Rabanal",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.97776,
                        "lon": -105.13193
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO",
            "description": "No plan to share IPD"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000053120",
                    "term": "Respiratory Aspiration"
                }
            ],
            "ancestors": [
                {
                    "id": "D000012120",
                    "term": "Respiration Disorders"
                },
                {
                    "id": "D000012140",
                    "term": "Respiratory Tract Diseases"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M27137",
                    "name": "Respiratory Aspiration",
                    "asFound": "Breathing",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14957",
                    "name": "Respiration Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14977",
                    "name": "Respiratory Tract Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        }
    },
    "hasResults": false
}